AlloVir scraps late-stage studies testing antiviral cell therapy

Kalaris Therapeutics

22/12/2023 12:10

Dec 22 (Reuters) - AlloVir  ALVR.O  said on Friday it
will discontinue three late-stage studies testing its
experimental antiviral cell therapy after an independent safety
board said the studies were unlikely to meet their main goals.  
 

 (Reporting by Mariam Sunny in Bengaluru; Editing by Devika
Syamnath)
 ((Mariam.ESunny@thomsonreuters.com;))